HLTH
🇦🇺 ASX
NULL AUSTRALIA
NULL GLOBAL
NULL US
NULL CHINA
NULL SMART BETA
NULL THEMATIC
NULL ASIA
NULL HEALTH
👑 Overview
📈 Performance
📙 Holdings
💰 Distributions
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
+ 0.67%
Annual Growth
5 years average annual capital growth
💰
0.60%
Annual distribution yield
Based on the most recent distribution
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
93
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
HLTH.AX was created on 2020-09-08 by VanEck. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investment returns before fees and other costs which track the performance of the Reference Index in Australian dollars.
📈 Performance
Price History
+3.07%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →📙 Top Holdings
Show more
Sonova Holding AG
2.34%
Genmab A/S
2.31%
Novo Nordisk A/S Class B
2.26%
Updated as of 25 May 2023
Industry Exposure
🩺 Health
100%
Country Exposure
🇺🇸 United States of America (the)
42%
🇩🇰 Denmark
20%
🇯🇵 Japan
19%
🇮🇪 Ireland
14%
🇰🇷 Korea (the Republic of)
10%
🇨🇭 Switzerland
9%
🇫🇷 France
9%
🇭🇰 Hong Kong
9%
💰 Distributions
Payouts
💰 Annual Distribution Yield*
0.60%
💰 Annual Distribution Earnings Per $1,000 invested**
$5.96
💰 Most Recent Distribution Franked Percentage Estimate
0.00%
💰 Average Distribution Franked Percentage Estimate
0.00 %
💰 Distribution reinvestment
* Based on the most recent distribution
** Calculated by multiplying the most recent distribution yield by $1,000
Distribution History
1Y
5Y
10Y
Graph
Table
Year
Yearly Distribution Earnings Per Share
Franking Estimate
2025
$0.00
0.00%
2024
$0.00
0.00%
2023
$0.00
0.00%
2022
$0.00
0.00%
2021
$0.04
0.00%
2020
$0.00
0.00%
2019
$0.00
0.00%
2018
$0.00
0.00%
2017
$0.00
0.00%
2016
$0.00
0.00%
💵 Costs
💼
0.45%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$10.41
💰 Price To Earnings Ratio
17.44
💰 Price To Book Ratio
4.26
💰 Leveraged
No
💰 Inverse
No
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in HLTH
93
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in HLTH
690 days
HLTH investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
22%
50k - 100k
38%
Less than 50k
33%
👶 Age of investors
18 - 25
12%
26 - 34
38%
35 - 90
51%
🙋 Legal gender of investors
Female
59%
Male
41%
Pearlers who invest in HLTH also invest in...
ACDC.AX was created on 2018-08-30 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the Solactive Battery ValueChain Index (the Index).
📊 Share price
$100.01 AUD
NULL GLOBAL
NULL OTHER
NULL SMART BETA
NULL THEMATIC
NULL INDEX
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
📊 Share price
$90.18 AUD
NULL AUSTRALIA
NULL BETA
VDHG.AX was created on 2017-11-20 by Vanguard. The fund's investment portfolio concentrates primarily on target outcome asset allocation. Vanguard Diversified High Growth Index ETF seeks to track the weighted average return of the various indices of the underlying funds in which it invests, in proportion to the Strategic Asset Allocation, before taking into account fees, expenses and tax.
📊 Share price
$57.36 AUD
NULL GLOBAL
NULL SMART BETA
ROBO.AX was created on 2017-09-13 by Global X. The fund's investment portfolio concentrates primarily on theme equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the ROBO.AX Global Robotics and Automation Index (the Index)
📊 Share price
$74.40 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
📊 Share price
$29.97 AUD
NULL GLOBAL
NULL SMART BETA
NULL ETHICAL
NULL THEMATIC
Want more shares? Try these...
Helix Resources Ltd. operates as an exploration company. The company is headquartered in Subiaco, Western Australia. The Company’s activity consists of advancing, discovering and developing primarily copper deposits in the Cobar region of central New South Wales. Its projects include the Collerina Copper Trend, Cobar Gold Project, and Canbelego Project. The Collerina Copper Project is located in the active copper/gold mining and exploration district known as the Cobar Basin, within central New South Wales, Australia. The project comprises a tenement package approximately 1,300 square kilometers (km2) approximately 100-kilometer (km) east of the town of Cobar and covers a 60 km copper-prospective trend, known as the Collerina Trend. The Cobar Gold Project is located over 30 km east-southeast of Aurelia's Peak Gold Operations and only 16 km from the privately owned Mount Boppy Gold Mine. The Canbelego Project covers an area of over 40 square km of copper perspective ground, located 45 km south-east of Cobar.
📊 Share price
$0.00 AUD
Healius Ltd. engages in the provision of healthcare technology solutions. The company is headquartered in Sydney, New South Wales and currently employs 11,000 full-time employees. The firm operates through two segments: Pathology, and Imaging. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment is a provider of imaging and scanning services at standalone imaging sites, hospitals, and medical centers. The firm has a network of pathology laboratories, collection centers, and diagnostic imaging centers. The company provides specialty diagnostic services to consumers and their referring practitioners. The Company’s brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. The firm provides healthcare services that are accessible and efficient while supporting the coordination and continuity of quality patient care.
📊 Share price